4.3 Review

The emerging role of high-dose-rate (HDR) brachytherapy as monotherapy for prostate cancer

Related references

Note: Only part of the references are listed.
Article Oncology

Long-term Survival and Toxicity in Patients Treated With High-Dose Intensity Modulated Radiation Therapy for Localized Prostate Cancer

Daniel E. Spratt et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)

Article Oncology

High-Dose-Rate Interstitial Brachytherapy as Monotherapy for Clinically Localized Prostate Cancer: Treatment Evolution and Mature Results

Nikolaos Zamboglou et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)

Article Oncology

Prostate cancer-specific mortality after definitive radiation therapy: Who dies of disease?

Michelle M. Kim et al.

EUROPEAN JOURNAL OF CANCER (2012)

Article Oncology

HIGH-DOSE-RATE BRACHYTHERAPY ALONE FOR LOCALIZED PROSTATE CANCER IN PATIENTS AT MODERATE OR HIGH RISK OF BIOCHEMICAL RECURRENCE

Peter Hoskin et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)

Article Oncology

HIGH-DOSE-RATE BRACHYTHERAPY AS A MONOTHERAPY FOR FAVORABLE-RISK PROSTATE CANCER: A PHASE II TRIAL

Maroie Barkati et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)

Article Oncology

LONG-TERM OUTCOMES FROM A PROSPECTIVE TRIAL OF STEREOTACTIC BODY RADIOTHERAPY FOR LOW-RISK PROSTATE CANCER

Christopher R. King et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)

Article Urology & Nephrology

High Dose Brachytherapy as Monotherapy for Intermediate Risk Prostate Cancer

C. Leland Rogers et al.

JOURNAL OF UROLOGY (2012)

Editorial Material Oncology

DOSE ESCALATION IN THE RADIATION THERAPY OF PROSTATE CANCER

Robert J. Schulz et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)

Article Oncology

DOSIMETRIC IMPACT OF INTERFRACTION CATHETER MOVEMENT IN HIGH-DOSE RATE PROSTATE BRACHYTHERAPY

William Foster et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)

Article Oncology

HIGH-DOSE-RATE MONOTHERAPY: SAFE AND EFFECTIVE BRACHYTHERAPY FOR PATIENTS WITH LOCALIZED PROSTATE CANCER

D. Jeffrey Demanes et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)

Article Oncology

ESTIMATION OF α/β FOR LATE RECTAL TOXICITY BASED ON RTOG 94-06

Susan L. Tucker et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)

Review Oncology

PELVIC NODAL RADIOTHERAPY IN PATIENTS WITH UNFAVORABLE INTERMEDIATE AND HIGH-RISK PROSTATE CANCER: EVIDENCE, RATIONALE, AND FUTURE DIRECTIONS

Lisa K. Morikawa et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)

Article Oncology

High-Dose-Rate Prostate Brachytherapy An Excellent Accelerated-Hypofractionated Treatment for Favorable Prostate Cancer

Alvaro A. Martinez et al.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2010)

Review Oncology

Extreme hypofractionation for prostate cancer

W. Robert Lee

EXPERT REVIEW OF ANTICANCER THERAPY (2009)

Article Oncology

A Phase II study of high-dose-rate afterloading brachytherapy as monotherapy for the treatment of localized prostate cancer

Carie Corner et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)

Article Oncology

Customized dose prescription for permanent prostate brachytherapy: Insights from a multicenter analysis of dosimetry outcomes

Nelson N. Stone et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)

Article Oncology

Analysis of serial CT scans to assess template and catheter movement in prostate HDR brachytherapy

E Mullokandov et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)

Article Oncology

How low is the alpha/beta ratio for prostate cancer?

JZ Wang et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)

Article Oncology

Is α/β for prostate tumors really low?

J Fowler et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)

Article Oncology

Needle displacement during HDR brachytherapy in the treatment of prostate cancer

SJ Damore et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)